Cargando…
Emerging roles of cytosolic phosphoenolpyruvate kinase 1 (PCK1) in cancer
Although it was traditionally believed that gluconeogenesis enzymes were absent from cancers that did not originate in gluconeogenic organs, numerous investigations have shown that they are functionally expressed in a variety of tumors as mediators of shortened forms of Gluconeogenesis. One of the i...
Autores principales: | Abate, Ebsitu, Mehdi, Mohammed, Addisu, Sisay, Degef, Maria, Tebeje, Solomon, Kelemu, Tsehayneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457690/ https://www.ncbi.nlm.nih.gov/pubmed/37637941 http://dx.doi.org/10.1016/j.bbrep.2023.101528 |
Ejemplares similares
-
Expanding the clinical spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency: novel PCK1 variants in four Arabian Gulf families
por: Al Busaidi, Marwa, et al.
Publicado: (2023) -
Epigenetic tumor heterogeneity in the era of single-cell profiling with nanopore sequencing
por: Ahmed, Yohannis Wondwosen, et al.
Publicado: (2022) -
Haematological Parameters in People with Atherosclerotic Cardiovascular Disease versus Those Who are Only at Risk for Cardiovascular Disease: A Comparative Cross-Sectional Study
por: Abate, Ebsitu, et al.
Publicado: (2023) -
Self-acetylation at the active site of phosphoenolpyruvate carboxykinase (PCK1) controls enzyme activity
por: Latorre-Muro, Pedro, et al.
Publicado: (2021) -
T3 and glucose increase expression of phosphoenolpyruvate carboxykinase (PCK1) leading to increased β-cell proliferation
por: Katz, Liora S., et al.
Publicado: (2022)